Baidu
map

抗核抗体检测的临床应用专家共识

2018-04-30 中国医师协会 中华检验医学杂志,2018,41(4) :275-280.

虽然上述国际、国内专家建议及共识对规范ANA的检测及明确其临床应用具有重要的意义,但目前尚缺乏适合我国国情的ANA检测的临床应用共识供临床及实验室遵循。因此,中国医师协会风湿免疫科医师分会自身抗体检测专业委员会于2017年9月组织了国内风湿免疫科、肾内科、健康体检、临床实验室及第三方检测实验室等多学科专家召开本共识的启动会。根据启动会提出的要求,由8位专家根据国内外相关文献并结合国内实际情况及中国

中文标题:

抗核抗体检测的临床应用专家共识

发布机构:

中国医师协会

发布日期:

2018-04-30

简要介绍:

虽然上述国际、国内专家建议及共识对规范ANA的检测及明确其临床应用具有重要的意义,但目前尚缺乏适合我国国情的ANA检测的临床应用共识供临床及实验室遵循。因此,中国医师协会风湿免疫科医师分会自身抗体检测专业委员会于2017年9月组织了国内风湿免疫科、肾内科、健康体检、临床实验室及第三方检测实验室等多学科专家召开本共识的启动会。根据启动会提出的要求,由8位专家根据国内外相关文献并结合国内实际情况及中国的ANA检测临床经验分别独立起草共识草案,随后对草案进行讨论汇总形成共识初稿。共识初稿经召开专家讨论会由所有专家组成员逐条审议讨论,达成一致意见后形成本共识。本共识的制定,旨在提高我国临床实验室对ANA检测的临床应用范围、临床意义解读等方面的认识水平,规范我国ANA检测方法、结果判断及结果报告,为临床提供规范可靠的ANA检测结果,以及ANA检测临床意义的正确理解和合理解释。 

拓展指南:自身免疫相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=抗核抗体检测的临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=e74dc1c001591863, title=抗核抗体检测的临床应用专家共识, enTitle=, guiderFrom=中华检验医学杂志,2018,41(4) :275-280., authorId=null, author=, summary=虽然上述国际、国内专家建议及共识对规范ANA的检测及明确其临床应用具有重要的意义,但目前尚缺乏适合我国国情的ANA检测的临床应用共识供临床及实验室遵循。因此,中国医师协会风湿免疫科医师分会自身抗体检测专业委员会于2017年9月组织了国内风湿免疫科、肾内科、健康体检、临床实验室及第三方检测实验室等多学科专家召开本共识的启动会。根据启动会提出的要求,由8位专家根据国内外相关文献并结合国内实际情况及中国, cover=, journalId=null, articlesId=null, associationId=1650, associationName=中国医师协会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>虽然上述国际、国内专家建议及共识对规范ANA的检测及明确其临床应用具有重要的意义,但目前尚缺乏适合我国国情的ANA检测的临床应用共识供临床及实验室遵循。因此,中国医师协会风湿免疫科医师分会自身抗体检测专业委员会于2017年9月组织了国内风湿免疫科、肾内科、健康体检、临床实验室及第三方检测实验室等多学科专家召开本共识的启动会。根据启动会提出的要求,由8位专家根据国内外相关文献并结合国内实际情况及中国的ANA检测临床经验分别独立起草共识草案,随后对草案进行讨论汇总形成共识初稿。共识初稿经召开专家讨论会由所有专家组成员逐条审议讨论,达成一致意见后形成本共识。本共识的制定,旨在提高我国临床实验室对ANA检测的临床应用范围、临床意义解读等方面的认识水平,规范我国ANA检测方法、结果判断及结果报告,为临床提供规范可靠的ANA检测结果,以及ANA检测临床意义的正确理解和合理解释。 </div> <div><br> </div> 拓展指南:<strong>与<font color="red">自身免疫</font>相关指南:</strong><br><ul><li><a title="2018 实践建议:接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=064b11c00156e7f0">2018 实践建议:接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理</a></li> <li><a title="《2017年欧洲儿科胃肠病、肝病和营养学会立场声明:儿童自身免疫性肝病的诊断和管理》摘译" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=658ac1c0015a2807">《2017年欧洲儿科胃肠病、肝病和营养学会立场声明:儿童自身免疫性肝病的诊断和管理》摘译</a></li> <li><a title="中国自身免疫性脑炎诊治专家共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=79b6b1c001a838e8">中国自身免疫性脑炎诊治专家共识</a></li> <li><a title="自身免疫性溶血性贫血诊断与治疗中国专家共识(2017年版)" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=d31f71c001ae01d0">自身免疫性溶血性贫血诊断与治疗中国专家共识(2017年版)</a></li> <li><a title="2016年国际胰腺病学协会《自身免疫性胰腺炎治疗专家共识》" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=b0b191c001a08258">2016年国际胰腺病学协会《自身免疫性胰腺炎治疗专家共识》</a></li> 更多信息请点击:<a target="_blank" href="//m.capotfarm.com/guideline/list.do?q=%E8%87%AA%E8%BA%AB%E5%85%8D%E7%96%AB">有关自身免疫更多指南</a></ul>, tagList=[TagDto(tagId=74908, tagName=抗核抗体检测), TagDto(tagId=611, tagName=临床应用)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7564, appHits=582, showAppHits=0, pcHits=5070, showPcHits=2950, likes=121, shares=31, comments=9, approvalStatus=1, publishedTime=Tue May 15 21:39:34 CST 2018, publishedTimeString=2018-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue May 15 21:39:34 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 19:13:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=抗核抗体检测的临床应用专家共识)])
抗核抗体检测的临床应用专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2190432, encodeId=cfc32190432fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3bf5548242, createdName=1553436, createdTime=Fri Mar 01 15:33:53 CST 2024, time=2024-03-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1057735, encodeId=d2cc105e73530, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b504808125, createdName=13743b1187m, createdTime=Tue Oct 05 02:10:03 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315762, encodeId=b69b315e621c, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Wed May 16 22:45:53 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315751, encodeId=07fb315e5181, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed May 16 22:32:01 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315453, encodeId=23c831545365, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue May 15 23:01:40 CST 2018, time=2018-05-15, status=1, ipAttribution=)]
    2024-03-01 1553436 来自广东省

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2190432, encodeId=cfc32190432fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3bf5548242, createdName=1553436, createdTime=Fri Mar 01 15:33:53 CST 2024, time=2024-03-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1057735, encodeId=d2cc105e73530, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b504808125, createdName=13743b1187m, createdTime=Tue Oct 05 02:10:03 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315762, encodeId=b69b315e621c, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Wed May 16 22:45:53 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315751, encodeId=07fb315e5181, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed May 16 22:32:01 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315453, encodeId=23c831545365, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue May 15 23:01:40 CST 2018, time=2018-05-15, status=1, ipAttribution=)]
    2021-10-05 13743b1187m

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2190432, encodeId=cfc32190432fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3bf5548242, createdName=1553436, createdTime=Fri Mar 01 15:33:53 CST 2024, time=2024-03-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1057735, encodeId=d2cc105e73530, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b504808125, createdName=13743b1187m, createdTime=Tue Oct 05 02:10:03 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315762, encodeId=b69b315e621c, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Wed May 16 22:45:53 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315751, encodeId=07fb315e5181, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed May 16 22:32:01 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315453, encodeId=23c831545365, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue May 15 23:01:40 CST 2018, time=2018-05-15, status=1, ipAttribution=)]
    2018-05-16 131****2916

    不错的文章值得推荐

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2190432, encodeId=cfc32190432fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3bf5548242, createdName=1553436, createdTime=Fri Mar 01 15:33:53 CST 2024, time=2024-03-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1057735, encodeId=d2cc105e73530, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b504808125, createdName=13743b1187m, createdTime=Tue Oct 05 02:10:03 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315762, encodeId=b69b315e621c, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Wed May 16 22:45:53 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315751, encodeId=07fb315e5181, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed May 16 22:32:01 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315453, encodeId=23c831545365, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue May 15 23:01:40 CST 2018, time=2018-05-15, status=1, ipAttribution=)]
    2018-05-16 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2190432, encodeId=cfc32190432fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3bf5548242, createdName=1553436, createdTime=Fri Mar 01 15:33:53 CST 2024, time=2024-03-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1057735, encodeId=d2cc105e73530, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b504808125, createdName=13743b1187m, createdTime=Tue Oct 05 02:10:03 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315762, encodeId=b69b315e621c, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Wed May 16 22:45:53 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315751, encodeId=07fb315e5181, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed May 16 22:32:01 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315453, encodeId=23c831545365, content=不错的文章值得推荐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Tue May 15 23:01:40 CST 2018, time=2018-05-15, status=1, ipAttribution=)]
    2018-05-15 131****2916

    不错的文章值得推荐

    0

Baidu
map
Baidu
map
Baidu
map